TransDigm's Q2 Earnings Surpass Estimates, Sales Increase Y/Y
📈 TransDigm reported Q2 fiscal 2026 adjusted earnings of $9.85 per share, exceeding analyst estimates by 5.7%.
💰 GAAP earnings reached $9.20 per share, up from $8.24 in the prior-year quarter.
📊 Total sales rose 18% year-over-year to $2.54 billion, surpassing the Zacks consensus of $2.42 billion.
🌱 Organic sales grew by 11% relative to total net sales.
💹 Gross profit increased significantly by 18.6% to $1.51 billion compared to the same quarter a year ago.
⚖️ Interest expenses climbed 28% to $484 million, while net income rose 11.9% to $536 million.
🔄 The company repurchased over 600,000 shares in Q2 for approximately $723 million at an average price of $1,201.
💵 Cash and cash equivalents grew to $3.89 billion as of March 28, 2026, up from $2.81 billion the previous year.
🏦 Long-term debt increased to $31.15 billion by the end of Q2 2026 from $29.2 billion in September 2025.
💸 Cash from operating activities jumped to $967 billion, a notable increase from $900 billion in the year-ago period.
🔮 TransDigm raised its full-year 2026 net sales guidance to $10.300–$10.420 billion, beating previous estimates and consensus.
📉 Revised adjusted earnings guidance for 2026 stands between $38.83 and $40.21 per share, above the midpoint of the consensus estimate.
🏷️ The article also briefly mentions earnings results for Teledyne Technologies, Lockheed Martin, and Textron in Q1 2026.
- TransDigm reported Q2 adjusted earnings of $9.85 per share, beating the Zacks Consensus Estimate of $9.32 by 5.7%.
- The company's sales increased 18% year-over-year to $2.54 billion, surpassing analyst expectations of $2.42 billion by 4.9%.
- Organic sales grew by 11%, demonstrating strong underlying demand for the company's core business segments.
- Gross profit expanded significantly by 18.6% to $1.51 billion compared to the prior-year period.
- Net income rose 11.9% year-over-year to $536 million, reflecting improved operational profitability.
- The company repurchased over 602,000 shares in the quarter for a total of $723 million, signaling confidence in its stock value.
- Cash and cash equivalents increased to $3.89 billion as of March 28, 2026, up from $2.81 billion the previous year.
- Management raised full-year guidance for net sales to a range of $10.30-$10.42 billion, significantly above the consensus estimate of $10.04 billion.
- Adjusted earnings guidance was also upgraded to a range of $38.83-$40.21 per share, indicating strong upside potential for the full year.
- TransDigm Group holds a Zacks Rank #4, which is the firm's highest rating indicating a 'Sell' recommendation based on its recent performance.
- The company's long-term debt has significantly increased to $31.15 billion as of March 28, 2026, up from $29.2 billion the previous quarter, raising leverage concerns despite higher cash reserves.
- Interest expenses have risen sharply by 28% year over year to $484 million, reflecting increased pressure on the company's bottom line due to debt servicing costs.